CD19 and lymphadenitis: Specifically, we studied contacts between CD3-positive T cells and CD19-positive reactive B cells in lymphadenitis and neoplastic B cells in DLBCL as well as CD30-positive lymphoma cells in MGZL, cHL, CD30-positive DLBCL.